Transaction · 0001673528-26-000002

Faga Daniel

Faga Daniel, PRES, CEO, reported a transaction classified as exercise at ANAPTYSBIO, INC involving 34677.000000 shares. Reported holdings after the transaction were 473448.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

exerciseSEC transaction code MPRES, CEO
ANABANAPTYSBIO, INC
Filing timeJan 07
Trade dateJan 03, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$45.21
Pre-filing
1mo ago -4.2%1w ago +10.8%1d ago -0.6%
Returns since
7d +11.2%30d +10.0%90d +37.4%180d +37.8%1y +26.1%

ANAB price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
ANAB since 2026-01-07Filed 241 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0001673528-26-000002
Common Stock
Transaction date
Jan 03, 2026
Filed Jan 07, 2026, 02:07 AM · 4d delay
Shares
34.6k sh
Price unknown
Estimated value
—
Computed from shares × price
Holdings after
473k sh
Direct

Filing warnings

Notes recorded with this filing
1 warning
missing priceThe filing did not provide a usable price per share.

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership
-2score
Filing-only score

-2

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

President, CEO

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

  2. F2

    Reflects the acquisition of 2,305 shares acquired under the Company's ESPP.

  3. F3

    The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax…

  4. F4

    The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Original filing · 0001673528-26-000002
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

ANAB